Dr. Reddy’s Laboratories: Realizing an ambitious vision
This case describes the challenges that Dr. Reddy’s Laboratories, the second largest pharmaceutical company in India in 2009, faced in making its vision (of becoming the first discovery-led global pharmaceutical company from India – “the Merck or Pfizer of India”) a reality. The company had grown from its very humble beginnings to become a $1.4 billion multinational in the space of 25 short years. Dr. Reddy’s early success was based on unbranded and branded generics. The company had a global presence and India revenues represented only 16% of the total. Dr. Reddy’s had built a world class manufacturing organization and was also expert at mounting patent challenges. Through a series of acquisitions, the company had assembled a high quality global supply chain. As the generics opportunity began to plateau, Dr. Reddy’s has recently sought to develop its skills in new drug discovery and marketing. The company has launched four new growth businesses: (1) the polypill project that seeks to combine proven generics in a single pill to provide more effective and low cost treatments for chronic diseases like cardiovascular disease (CVD), depression and osteoarthritis; (2) a specialty dermatology business in the US; (3) high-margin (and high-risk) drug discovery, with five New Chemical Entities in the pipeline as of 2009; and (4) biologics, an exciting and fast-growing segment of the pharmaceuticals industry. The challenge for the student is to analyze how these dots are connected and whether these initiatives are sufficient for the company to realize its ambitious vision. The case also discusses how the company’s CEO, GV Prasad, has restructured the organization to help realize its vision and has sought to attract and retain the new kind of talent that would be needed in this effort.
The case is a good vehicle to discuss the changing landscape of the global pharmaceuticals industry. It is also useful for discussing the strategies of emerging global contenders from BRIC countries. Third, the case presents a rich backdrop for discussing how companies should manage the risks involved in corporate renewal. Should Dr. Reddy’s focus on what it is good at, i.e. generics and related products and services; or should it venture into the higher-margin but higher-risk discovery-led business? How can it do both?
2003 - 2009
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
Case B describes the unprecedented challenges faced by CO-RO in 2020. The implementation of the sugar tax in its largest Middle Eastern market led to a near 50% volume drop in CO-RO’s sales, and Covid-19 lockdowns impacted the Asia-Pacific (APAC) ...
The CO-RO Group is a manufacturer of fruit-based still drinks, concentrates and ambient ice (home-freeze popsicles) headquartered in Denmark. Although production takes place in Denmark, most of its products are sold internationally, with the compa...
The case explores TBC Bank Group’s remarkable journey from a small Georgian bank to a regional leader in digital financial services across Central Asia. Founded in 1992 with just US$500 in initial capital, TBC evolved into Georgia’s largest financ...

The board of Nestlé S.A. announced that Anna Mohl would become the CEO of Nestlé Health Science (NHSc) — a global leader in nutritional science — on 1 January 2024. She was delighted to hear about her new position but knew there was little time to...

Are you struggling to lead successfully in the face of relentless disruption and uncertainty? Now’s the time to master the art of strategic thinking, starting with these six key skills.

An easy-to-use tool can help executives assess and manage the impact of stakeholders on the creation and destruction of value.

Medical experts have long warned about alcohol's risks, and now the drinks industry is embracing sobriety, investing in innovative alcohol-free drinks alternatives.

Manuel Reman combines Krug’s tradition with innovation, prioritizing authenticity and sustainability to keep the champagne house relevant in evolving times.

Being able to think strategically is key to addressing the ever-increasing demands on leaders – but it's easier said than done. Here are four key capabilities that will help you succeed in turbulent times.
The China Resources Beer (CR Beer) case study is a compelling narrative of the world’s largest beer producer by volume under the leadership of CEO Hou Xiaohai. In 2016 CR Beer embarked on a pivotal transformation journey. This case study offers cr...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-7-2636 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD Brain Circuits 28 January 2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications